Dirk Sibbing’s Editorial on Sex Differences in DAPT De-escalation After PCI
Dirk Sibbing, Professor, Cardiologist and Angiologist at Lauterbacher Mill Private Clinic and LMU Munich, shared a post on LinkedIn:
“More insights into treatment effect modifiers of dual antiplatelet therapy (DAPT)!
Sex matters, and we are moving more and more towards a more personalized antiplatelet treatment post PCI
See the coverage on TCTMD on the great paper by Mattia Galli in EHJ and my accompanying Editorial.”
Title: Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis
Authors: Giovanni Occhipinti, Claudio Laudani, Mattia Galli, Luis Ortega-Paz, Vijay Kunadian, Guiomar Mendieta, Riccardo Rinaldi, Felicita Andreotti, Roxana Mehran, Teresa López-Sobrino, Davide Capodanno, Dominick J Angiolillo, Manel Sabaté Tenas, Salvatore Brugaletta
Read the full paper here.
Check for the Editorial here.
Stay updated with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp